ELDON BIOLOGICALS A/S: Financial statements 2025
CVR: 26747007
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. That is a decrease of 8.3% compared with the year before. Equity in the 2025 report amounted to DKK 42,055,949. The solvency ratio was 87.8%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 13,635,058
- Profit/Loss
- DKK 3,900,353
- Equity
- DKK 42,055,949
- Total Assets
- DKK 47,875,459
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 13.6 mio. | 3.9 mio. | 42.1 mio. | 12 |
| 2024 | - | 14.9 mio. | 6.7 mio. | 40.2 mio. | 10 |
| 2023 | - | 12.3 mio. | 5.4 mio. | 34.5 mio. | 10 |
| 2022 | - | 16.4 mio. | 5 mio. | 29.6 mio. | 9 |
| 2021 | - | 19.5 mio. | 9.1 mio. | 25.1 mio. | 11 |
Official annual report
How creditworthy is ELDON BIOLOGICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.